The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learnt
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Self-citationPolymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Self-citationDe Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Structure and properties of pharmacologically active polymers
Ringsdorf, H. (1975) · Journal of Polymer Science: Polymer Symposia · doi:10.1002/polc.5070510111 · Cited by 1,094
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
Self-citationGreco, F., & Vicent, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.006 · Cited by 652
HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of action
Kopecek, J. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00075-8 · Cited by 562
Dittmer, J. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-29 · Cited by 509
Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., & Maeda, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00563.x · Cited by 470
Self-citationDrug-polymer conjugates: potential for improved chemotherapy
Duncan, R. (1992) · Anti-Cancer Drugs · doi:10.1097/00001813-199206000-00001 · Cited by 444
Self-citationPolymer-drug conjugates: Recent development in clinical oncology
Li, C., & Wallace, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.009 · Cited by 436
Seymour, L. W., Duncan, R., Strohalm, J., & Kopeček, J. (1987) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820211106 · Cited by 436
Self-citationHepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
Satchi-Fainaro, R., Puder, M., Davies, J. W., Tran, H. T., Sampson, D. A., Greene, A. K., Corfas, G., & Folkman, J. (2004) · Nature Medicine · doi:10.1038/nm1002 · Cited by 345
Seymour, L. W., Miyamoto, Y., Maeda, H., Brereton, M., Strohalm, J., Ulbrich, K., & Duncan, R. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00514-6 · Cited by 337
Self-citationSoluble synthetic polymers as potential drug carriers
Duncan, R., & Kopeček, J. (1984) · Advances in Polymer Science · doi:10.1007/3-540-12796-8_10 · Cited by 318
Self-citationSeymour (2009) · International Journal of Oncology · doi:10.3892/ijo_00000293 · Cited by 304
Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization
Kopeček, J., & Baẑilová, H. (1973) · European Polymer Journal · doi:10.1016/0014-3057(73)90063-3 · Cited by 300
Meerum Terwogt, J. M., ten Bokkel Huinink, W. W., Schellens, J. H., Schot, M., Mandjes, I. A., Zurlo, M. G., Rocchetti, M., Rosing, H., Koopman, F. J., & Beijnen, J. H. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200104000-00003 · Cited by 279
Lammers, T., Subr, V., Ulbrich, K., Peschke, P., Huber, P. E., Hennink, W. E., & Storm, G. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.040 · Cited by 240
Rademaker-Lakhai, J. M., Terret, C., Howell, S. B., Baud, C. M., de Boer, R. F., Pluim, D., Beijnen, J. H., Schellens, J. H. M., & Droz, J.-P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0315 · Cited by 214
Polymer Therapeutics Designed for a Combination Therapy of Hormone‐Dependent Cancer
Vicent, M. J., Greco, F., Nicholson, R. I., Paul, A., Griffiths, P. C., & Duncan, R. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200462960 · Cited by 199
Self-citationDuncan, R., Cable, H. C., Lloyd, J. B., Rejmanová, P., & Kopeček, J. (1983) · Die Makromolekulare Chemie · doi:10.1002/macp.1983.021841005 · Cited by 193
Self-citationBiocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin
Rihova, B., Bilej, M., Vetvicka, V., Ulbrich, K., Strohalm, J., Kopecek, J., & Duncan, R. (1989) · Biomaterials · doi:10.1016/0142-9612(89)90075-6 · Cited by 192
Self-citationPreclinical evaluation of polymer-bound doxorubicin
Duncan, R., Seymour, L. W., O'Hare, K. B., Flanagan, P. A., Wedge, S., Hume, I. C., Ulbrich, K., Strohalm, J., Subr, V., Spreafico, F., et al. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90088-9 · Cited by 187
Self-citationGianasi, E., Wasil, M., Evagorou, E. G., Keddle, A., Wilson, G., & Duncan, R. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00030-1 · Cited by 186
Self-citationPaz-Ares, L., Ross, H., O'Brien, M., Riviere, A., Gatzemeier, U., Von Pawel, J., Kaukel, E., Freitag, L., Digel, W., Bischoff, H., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604372 · Cited by 171
Polymer Conjugates: Pharmacokinetic Considerations for Design and Development
Duncan, R., & Spreafico, F. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199427040-00004 · Cited by 164
Self-citationSeymour, L., Ulbrich, K., Steyger, P., Brereton, M., Subr, V, Strohalm, J., & Duncan, R. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.363 · Cited by 164
Self-citationŘíhová, B. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00404-8 · Cited by 162
Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD)
Danhauser-riedl, S., Hausmann, E., Schick, H.-D., Bender, R., Dietzfelbinger, H., Rastetter, J., & Hanauske, A.-R. (1993) · Investigational New Drugs · doi:10.1007/bf00874153 · Cited by 152
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy
Lammers, T., Šubr, V., Peschke, P., Kühnlein, R., Hennink, W. E., Ulbrich, K., Kiessling, F. M., Heilmann, M., Debus, J., Huber, P. E., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604561 · Cited by 141
Rejmanová, P., Kopec̆ek, J., Duncan, R., & Lloyd, J. B. (1985) · Biomaterials · doi:10.1016/0142-9612(85)90037-7 · Cited by 138
Self-citationDUNCAN, R., Seymour, L. W., Scarlett, L., LLOYD, J., Rejmanová, P., & Kopeček, J. (1986) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(86)90120-0 · Cited by 130
Self-citationDo molecularly targeted agents in oncology have reduced attrition rates?
Walker, I., & Newell, H. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2758 · Cited by 130
Duncan, R., Kopec̆ek, J., Rejmanová, P., & Lloyd, J. B. (1983) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(83)90258-1 · Cited by 127
Self-citationChipman, S. D., Oldham, F. B., Pezzoni, G., & Singer, J. W. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.4.375 · Cited by 125
Bissett, D., Cassidy, J., Bono, J. S. D., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601922 · Cited by 125
Polymeric Drug Delivery Systems
Kim, S. W., Petersen, R. V., & Feijén, J. (1980) · Elsevier eBooks · doi:10.1016/b978-0-12-060310-7.50010-9 · Cited by 125
Gaspar, R. S. (2007) · Nanomedicine · doi:10.2217/17435889.2.2.143 · Cited by 124
A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin
Schoemaker, N. E., van Kesteren, C., Rosing, H., Jansen, S., Swart, M., Lieverst, J. A., Fraier, D., Breda, M., Pellizzoni, C., Spinelli, R., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600516 · Cited by 122
Seymour, L. W., Ulbrich, K., Wedge, S. R., Hume, I. C., Strohalm, J., & Duncan, R. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.190 · Cited by 117
Self-citationRice, J. R., Gerberich, J. L., Nowotnik, D. P., & Howell, S. B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2169 · Cited by 117
Campone, M., Rademaker-Lakhai, J. M., Bennouna, J., Howell, S. B., Nowotnik, D. P., Beijnen, J. H., & Schellens, J. H. M. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0397-0 · Cited by 115
Shaffer, S. A., Baker-Lee, C., Kennedy, J., Lai, M. S., de Vries, P. W., Buhler, K. R., & Singer, J. W. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0296-4 · Cited by 104
Chytil, P., Etrych, T., Koňák, Č., Šírová, M., Mrkvan, T., Říhová, B., & Ulbrich, K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.028 · Cited by 99
Nanoparticulate carriers for the treatment of coronary restenosis.
Brito, L., & Amiji, M. M. (2007) · PubMed Central · Cited by 99
Polymeric Drug Delivery Systems
(2005) · CRC Press eBooks · doi:10.1201/9780849348129 · Cited by 98
Sood, P., Thurmond, K. B., Jacob, J. E., Waller, L. K., Silva, G. O., Stewart, D. R., & Nowotnik, D. P. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0600517 · Cited by 92
Greco, F., Vicent, M. J., Gee, S., Jones, A. T., Gee, J. M. W., Nicholson, R. I., & Duncan, R. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.012 · Cited by 90
Self-citationKopec̆ek, J. (1977) · Die Makromolekulare Chemie · doi:10.1002/macp.1977.021780804 · Cited by 84
Tyrosinamide residues enhance pinocytic capture of N-(2-hydroxypropyl)methacrylamide copolymers
Duncan, R., Cable, H. C., Rejmanová, P., Kopec̆ek, J., & LLOYD, J. (1984) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(84)90320-9 · Cited by 81
Self-citationYeung, T. K., Hopewell, J. W., Simmonds, R. H., Seymour, L. W., Duncan, R., Bellini, O., Grandi, M., Spreafico, F., Strohalm, J., & Ulbrich, K. (1991) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00687318 · Cited by 77
Self-citationPreclinical toxicology of a novel polymeric antitumour agent: HPMA copolymer-doxorubicin (PK1)
Duncan, R., Coatsworth, J. K., & Burtles, S. S. (1998) · Human & Experimental Toxicology · doi:10.1177/096032719801700204 · Cited by 76
Self-citationDuncan, R., Pratten, M. K., Cable, H. C., et al. (1981) · Biochemical Journal · doi:10.1042/bj1960049 · Cited by 75
Self-citationHopewell, J. W., Duncan, R., Wilding, D., & Chakrabarti, K. (2001) · Human & Experimental Toxicology · doi:10.1191/096032701682693017 · Cited by 72
Self-citationGianasi, E., Buckley, R. G., Latigo, J. R., Wasil, M., & Duncan, R. (2002) · Journal of drug targeting · doi:10.1080/1061186021000072456 · Cited by 64
Self-citationBIODEGRADATION OF POLYMERS FOR BIOMEDICAL USE
Kopec̆ek, J. (1982) · Elsevier eBooks · doi:10.1016/b978-0-08-026226-0.50026-9 · Cited by 63
Improved targeting of platinum chemotherapeutics
Lin, X., Zhang, Q., Rice, J. R., Stewart, D. R., Nowotnik, D. P., & Howell, S. B. (2003) · European Journal of Cancer · doi:10.1016/j.ejca.2003.09.022 · Cited by 56
Handbook of Anticancer Drug Development
Budman, D. R., Calvert, H., Rowinsky, E. K., & Hill, B. T. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200411000-00011 · Cited by 55
pH-sensitive hemolysis by random copolymers of alkyl acrylates and acrylic acid
Murthy, N., Chang, I., Stayton, P. S., & Hoffman, A. S. (2001) · Macromolecular Symposia · doi:10.1002/1521-3900(200107)172:1<35::aid-masy35>3.0.co;2-n · Cited by 53
Paul, A., Vicent, M. J., & Duncan, R. (2007) · Biomacromolecules · doi:10.1021/bm060925s · Cited by 52
Self-citationAcquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs
Říhová, B., Strohalm, J., Kubáčková, K., Jelínková, M., Hovorka, O., Kovář, M., Plocová, D., Šírová, M., Šťastný, M., Rozprimová, L., et al. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00489-8 · Cited by 49
Seib, F. P., Jones, A. T., & Duncan, R. (2006) · Journal of drug targeting · doi:10.1080/10611860600833955 · Cited by 46
Self-citationSynthetic approaches to uniform polymers☆
Ali, M. S., & Brocchini, S. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.10.002 · Cited by 45
N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates
Duncan, R. (2005) · CRC Press eBooks · doi:10.1201/9780849348129-4 · Cited by 44
Self-citationImmunological problems of polymer-bound drugs.
Rihova, B., & Říha, I. (1985) · PubMed · Cited by 41
Cytotoxicity and immunostimulation: double attack on cancer cells with polymeric therapeutics
Říhová, B., Kovář, L., Kovář, M., & Hovorka, O. (2008) · Trends in biotechnology · doi:10.1016/j.tibtech.2008.10.006 · Cited by 40
Pimm, M. V., Perkins, A. C., Duncan, R., & Ulbrich, K. (1993) · Journal of drug targeting · doi:10.3109/10611869308996068 · Cited by 39
Self-citationHPMA copolymer–aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines
Greco, F., Vicent, M. J., Penning, N. A., Nicholson, R. I., & Duncan, R. (2005) · Journal of drug targeting · doi:10.1080/10611860500383788 · Cited by 36
Self-citationKasuya, Y., Lu, Z., Kopečková, P., Tabibi, S. E., & Kopeček, J. (2002) · Pharmaceutical Research · doi:10.1023/a:1014216712820 · Cited by 31
HPMA Copolymer-1,5-Diazaanthraquinone Conjugates as Novel Anticancer Therapeutics
Vicent, M. J., Manzanaro, S., de la Fuente, J. Á., & Duncan, R. (2004) · Journal of drug targeting · doi:10.1080/10611860400011901 · Cited by 23
Self-citation
Cited by
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324
Metadata
- Authors
- Duncan, R.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 61
- Issue
- 13
- Pages
- 1131-1148
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2077405964
- Cited by
- 252
- References
- 74
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.